Search

39 results for “cardiovascular”

• Research LetterOpen Access

  Cardiovascular medications among the critically ill patients of a tertiary care hospital: A drug utilization study

  Lisha Jenny John, Padmini Devi, Shoba Guido

  Vol. 4 · Issue 4 · pp. 285–287

  https://doi.org/10.4103/0976-500X.119717
  Full text ↗PDF

• Book ReviewOpen Access

  Pathophysiology and pharmacology of cardiovascular disease

  Raja J. Selvaraj

  Vol. 7 · pp. 55–55

  Full text ↗PDF

• News and ViewsOpen Access

  Antibiotics with a curse of cardiovascular risk

  G Sivagnanam

  Vol. 5 · Issue 1 · pp. 71–72

  Full text ↗PDF

• Research LetterOpen Access

  Prescribing pattern of drugs for cardiovascular co-morbidities in type 2 diabetes mellitus in a tertiary care Indian hospital

  Dakshinamurthy Nishanthini, Balan Aravinda Kumar, Chandrashekaran Girish, Sadasivam Balakrishnan

  Vol. 5 · Issue 1 · pp. 54–55

  https://doi.org/10.4103/0976-500X.124424
  Full text ↗PDF

• MethodsOpen Access

  Measurement of invasive blood pressure in rats

  Subramani Parasuraman, Ramasamy Raveendran

  Vol. 1 · Issue 2 · pp. 87–93

  https://doi.org/10.4103/0976-500X.95521
  Full text ↗PDF

• News and ViewsOpen Access

  Chronotherapy in hypertension

  Vol. 3 · pp. 209–209

  Full text ↗PDF

• Research LettersOpen Access

  Platelet aggregation inducing activity of Ficus racemosa stem bark extracts

  Faiyaz Ahmed, Kumar S., Asna Urooj, Kemparaju K.

  Vol. 3 · Issue 4 · pp. 329–330

  https://doi.org/10.4103/0976-500X.103692
  Full text ↗PDF

• Mini ReviewOpen Access

  Statin induced diabetes and its clinical implications

  Umme Aiman, Ahmad Najmi, Rahat Ali Khan

  Vol. 5 · Issue 3 · pp. 181–185

  https://doi.org/10.4103/0976-500X.136097
  Full text ↗PDF

• Educational ForumOpen Access

  Saxagliptin: A dipeptidyl peptidase-4 inhibitor in the treatment of type 2 diabetes mellitus

  Darshan J. Dave

  Vol. 2 · Issue 4 · pp. 230–235

  https://doi.org/10.4103/0976-500X.85934
  Full text ↗PDF

• Research ArticleOpen Access

  Retrospective evaluation of adverse drug reactions induced by antihypertensive treatment

  Pierandrea Rende, Laura Paletta, Giuseppe Gallelli, Gianluca Raffaele, Vincenzo Natale, Nazareno Brissa, Cinzia Costa, Santo Gratteri, Chiara Giofrè, Luca Gallelli

  Vol. 4 · Issue Supplement 1 · pp. S47–S48

  https://doi.org/10.4103/0976-500X.120954
  Full text ↗PDF

• Research ArticleOpen Access

  Competitive Analysis of the Binding Affinity of Montelukast, Zafirlukast and Gemilukast to CysLTR1, P2Y12 and PPAR-γ and their Possible Cardioprotective Effect: Using in silico Methods

  Matrika Saha Roy, Bidduth Kumar Sarkar, Md Rohan Nadvi, Arghya Prosun Sarkar, Sukalyan Kumar Kundu, Hossain Ahmed, Md Jahirul Islam, Barno Kumar Sarkar, Peter Singh, Tanushree Maitra, Maruf Hasan

  Vol. 15 · Issue 1 · pp. 28–37

  https://doi.org/10.1177/0976500X241232235
  Full text ↗PDF

• Mini ReviewOpen Access

  Iptakalim: A novel multi-utility potassium channel opener

  (Kir6.1s) (Kir6.1s), regulatory sulphonylurea subunits (SUR).[3] IPT shows high selectivity for cardiac KATP (SUR2A/Kir6.2), vascular KATP (SUR2B/Kir6.1 or SUR6B/Kir6.2). Because

  Vol. 3 · Issue 1 · pp. 12–14

  https://doi.org/10.4103/0976-500X.92495
  Full text ↗PDF

• News and reviewOpen Access

  News and review

  Vol. 5 · Issue 1 · pp. 220–220

  Full text ↗PDF

• Case ReportOpen Access

  Life‑threatening bradyarrhythmia with oral phenytoin overdose

  Giridharan Srinivasan, Mukta Wyawahare, Pratheesh George Mathen, Dharanipragada K.

  Vol. 6 · Issue 3 · pp. 179–181

  https://doi.org/10.4103/0976-500X.162017
  Full text ↗PDF

• Research LettersOpen Access

  Wound healing activity of Hemidesmus indicus formulation

  S. Ganesan, S. Parasuraman, S. Uma Maheswaran, N. Gnanasekar

  Vol. 3 · Issue 1 · pp. 66–67

  https://doi.org/10.4103/0976-500X.92516
  Full text ↗PDF

• CommentaryOpen Access

  The new factor Xa inhibitor: Apixaban

  Sangeeta Bhanwra, Kaza Ahluwalia

  Vol. 5 · Issue 1 · pp. 12–14

  https://doi.org/10.4103/0976-500X.124409
  Full text ↗PDF

• CommentaryOpen Access

  The metabolic syndrome and schizophrenia: A comorbidity or an association?

  Vol. 4 · Issue 3 · pp. 174–175

  Full text ↗PDF

• Molecules of MillenniumOpen Access

  Proprotein convertase subtilisin/kexin type 9 enzyme inhibitors: An emerging new therapeutic option for the treatment of dyslipidemia

  Faizan Mazhar, Nafis Haider

  Vol. 7 · Issue 4 · pp. 190–3

  https://doi.org/10.4103/0976-500X.195906
  Full text ↗PDF

• Research LetterOpen Access

  Incidence of metabolic syndrome in breast cancer survivors on adjuvant hormonal therapy

  Anahita Kate, Dharanipragada Kadambari

  Vol. 7 · Issue 1 · pp. 28–30

  https://doi.org/10.4103/0976-500X.179362
  Full text ↗PDF

• ReportOpen Access

  The basic concepts of scientific research and scientific communication

  Pitchai Balakumar, Gowraganahalli Jagadeesh

  Vol. 3 · Issue 2 · pp. 178–179

  https://doi.org/10.4103/0976-500X.95522
  Full text ↗PDF